In this context, utilizing network pharmacology, in vitro and cellular assays, we explored Asp G’s potential anti-PD mechanisms and its influence on PD-like neuroinflammatory pathology, along with its anti-inflammatory potential via MMP9 suppression. This evidence concerns the gene MMP9 and Parkinson disease.